Showing 9551-9560 of 20352 results for "".
- Tirzepatide vs Intensified Conventional Care at 2 Years in Early T2Dhttps://reachmd.com/news/tirzepatide-vs-intensified-conventional-care-at-2-years-in-early-t2d/2487296/Key Takeaways Tirzepatide was associated with greater reductions in HbA1c, weight, and waist circumference than intensified conventional care over 2 years. More participants achieved normoglycemia with tirzepatide than with intensified conventional car
- Study: JAK Inhibitor–Excimer Laser Combination Improves Repigmentation in Pediatric Vitiligohttps://reachmd.com/news/jak-inhibitorexcimer-laser-combination-improves-repigmentation-in-pediatric-vitiligo-trial/2487301/Children with progressive vitiligo treated with an oral Janus kinase (JAK) inhibitor combined with 308-nm excimer laser therapy experienced significantly greater repigmentation than those treated with topical tacrolimus and excimer laser therapy, according to
- Strategies That Improved Childhood Routine Immunization Coveragehttps://reachmd.com/news/strategies-that-improved-childhood-routine-immunization-coverage/2487271/Key Takeaways Across 28 identified strategies, consistent gains were reported for cash transfers, home-based identification and outreach, and informational vaccination sessions. Cash transfers showed small gains, home-based outreach showed small-to-mod
- Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: Phase 3 Datahttps://reachmd.com/news/inhaled-treprostinil-in-idiopathic-pulmonary-fibrosis-phase-3-data/2487213/Key Takeaways Median forced vital capacity decline at week 52 was smaller with treprostinil than with placebo. Clinical worsening occurred in 31.8% versus 44.5%, with a hazard ratio of 0.67, and no significant difference was seen in time to IPF exacerb
- Upadacitinib Plus Vedolizumab Induction in Moderate-To-Severe UChttps://reachmd.com/news/upadacitinib-plus-vedolizumab-induction-in-moderate-to-severe-uc/2487220/Key Takeaways Endoscopic remission was observed more often with combination induction than with vedolizumab alone at the week-8 assessment. Combination therapy also showed higher clinical remission and histologic-endoscopic mucosal improvement at week
- LNG IUS Outperformed Hysteroscopic Niche Resection At 3 Yearshttps://reachmd.com/news/lng-ius-outperformed-hysteroscopic-niche-resection-at-3-years/2487221/Key Takeaways Women assigned the levonorgestrel intrauterine system were more likely to meet the primary spotting reduction endpoint at 36 months. Improvement with the device continued through 36 months, while the hysteroscopic group improved through 2
- Swiftscope App Integrates Dermatoscopy With SwiftPro Wart Treatmentshttps://reachmd.com/news/swiftscope-app-integrates-dermatoscopy-with-swiftpro-wart-treatments/2487231/Emblation has launched the Swiftscope app, a new digital imaging platform designed to help clinicians visually monitor treatment progress in patients undergoing SwiftPro microwave therapy for common and plantar warts, according to a news release. The announcement f
- Dual-Site aiTBS Reduces Suicidal Ideation in Adolescents With MDDhttps://reachmd.com/news/dual-site-aitbs-reduces-suicidal-ideation-in-adolescents-with-mdd/2487182/Key Takeaways Dual-site aiTBS was associated with a greater short-term reduction in suicidal ideation than single-site left DLPFC stimulation over 4 days. Daily suicidal ideation trajectories and day-4 depression response and remission rates also favor
- Randomized Shunt Trial in iNPH Shows Gait Benefithttps://reachmd.com/news/randomized-shunt-trial-in-inph-shows-gait-benefit/2487199/Key Takeaways Open shunting was associated with greater 3-month improvement in gait velocity than the placebo valve setting in this drainage-responsive group. Tinetti scores favored open shunting, while MoCA and Overactive Bladder Questionnaire scores
- Peripheral Neuropathy in IgA Gammopathy: Prevalence And Red Flagshttps://reachmd.com/news/peripheral-neuropathy-in-iga-gammopathy-prevalence-and-red-flags/2487198/Key Takeaways Neuropathy was documented in 13.5% of the cohort, and most affected patients were classified as having neuropathy unrelated to IgA. The rare IgA-related subgroup was observed mainly in AL amyloidosis and POEMS syndrome rather than across